星空游戏网站免费进入|星空彩票电脑版

Abstract

Abstract:

Vascular dementia （VaD） is a type of cerebrovascular diseases that can cause brain damages，which is mainly characterized by cognitive capacity，learning and memory decline. As vascular factors are the main factors affecting their onset. Chronic cerebral hypoperfusion is an important risk factor for cognitive dysfunction of the body caused by vascular dysfunction，so the suitable animal model is an important mean to study its pathological mechanism. This article outlines the pathological mechanism of cerebral vascular disease caused by cerebral hypoperfusion in the development of cognitive dysfunction and dementia and the production of several commonly used experimental chronic cerebral hypoperfusion animal models，and explore the correlation with the pathological mechanism of cerebral vascular diseases，in order to provide suitable animal models for the study of drug-interventional chronic cerebral hypoperfusion-induced vascular dementia and references for the mechanisms researchs of clinical drugs.

Key words:chronic cerebral hypoperfusion,cerebral ischemia,vascular dementia,cerebral small vessel disease,pathological factors,animal models

CLC Number:

R332

SUN Cheng-cheng，LIU Jian-gang，LIU Mei-xia，LI Hao，LUO Zeng-gang.Exploration of Pathological Mechanism of Vascular Dementia Induced by Chronic Cerebral Hypoperfusion and Production of Several Common Animal Models[J]. Acta Neuropharmacologica,DOI: 10.3969/j.issn.2095-1396.2019.01.003.

References

[1]Miranka Wirth, Alexa Pichet Binette, Peter Brunecker, et al. Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients[J]. J Cereb Blood Flow Metab, 2017, 37(3): 814-824.
[2]Philip B Gorelick, Scott E Counts, David Nyenhuis. Vascular cognitive impairment and dementia[J]. Biochim Biophys Acta, 2016, 1862 (5):860-868.
[3]Zhao Yang, Gong Cheng-xin. From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration [J].Cell Mol Neurobiol, 2015, 35(1): 101-110.
[4]Anli M Tuladhar, Anouk G W van Norden, Karlijn F de Laat, et al. White matter integrity in small vessel disease is related to cognition[J].Neuroimage Clin, 2015, 7: 518-524.
[5]Leonardo Pantoni, Fabio Fierini, Anna Poggesi. Thrombolysis in Acute stroke patients with cerebral small vessel disease[J]. Cerebrovasc Dis, 2014, 37(1): 5-13.
[6]Blinder P, Tsai P S, Kaufhold J P, et al. Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment[J].Stroke, 2013, 40(Supple): S48-S52.
[7]Antonio Coca. Hypertension and vascular dementia in the elderly: the potential role of anti-hypertensive agents[J]. Curr Med Res Opin, 2013, 29(9): 1045-1054.
[8]Zoe Arvanitakis, Ana W Capuano, Sue E Leurgans, et al. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly People: a cross-sectional study[J].Lancet Neurol, 2016, 15(9): 934-943.
[9]Michelle M Miller-Thomas, Adam L Sipe, Tammie L S Benzinger, et al. Multimodality review of amyloid-related diseases of the central nervous system[J].Radiographics, 2016, 36(4): 1147-1163.
[10]Laibaik Park, Kenzo Koizumi, Sleiman EI Jama, et al. Age-dependent neurovascular dysfunction and damage in a mouse model of cerebral amyloid angiopathy[J].Stroke, 2014, 45(6): 1815-1821.
[11]R Douglas Fields. Neuroscience. Change in the brain＇s white matter[J]Science, 2010, 330(6005): 768-769.
[12]Robert Bell, Rashid Deane, Nienwen Chow, et al. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells[J].Nat Cell Biol, 2010, 11(2): 143-153.
[13] 徐运.认知障碍性疾病早期诊断的临床研究[J].神经药理学报,2017,7(02):9.
[14] Adria Arboix, Lorena Blanco-Rojas, Josep LIuis Marti-Vilalta. Advancements in understanding the mechanisms of symptomatic lacunar ischemicstroke: translation of knowledge to prevention strategies[J].Expert Rev Neurother, 2014, 14(3) : 261-276．
[15] Lv P，Jin Hai-qiang，Liu Yuan-yuan，et al．Comparison of risk factor between lacunar stroke and large artery atherosclerosis stroke: A cross-sectional study in China[J].PLos One，2016, 11(3) : e0149605．
[16]Jason D Hinman，Monica D Lee，Spencer Tung，et al．Molecular disorganization of axons adjacent to human lacunar infarcts[J].Brain, 2015, 138 ( Pt 3) : 736-745．
[17] 李江曼,王一頔,王风萍,等.脑缺血再灌注损伤及其星形胶质细胞相关机制研究进展[J].神经药理学报,2017,7(6):50-59.
[18]Andreas Charidimou, Sergi Martinez-Ramirez, Yael Reijmer, et al. Total magnet is resonance imaging bueden of small vessel desease in cerebral amyloid angiopathy an imaging-pathologic study of concept validation[J].JAMA Neurol, 2016, 73(8): 994-1001.
[19]Saloua Akoudad, Frank J Wolters, Anand Viswanathan, et al. Association of cerebral microbleeds with cognitive decline and dementia[J].JAMA Neurol, 2016, 73(8): 934-943.
[20] 何婧，黄燕，杜果，等.慢性脑低灌注致模型大鼠学习记忆受损及海马α-突触核蛋白变化[J].中国组织工程研究,2018,22(20):3230-3236.
[21]Kassandra Kisler, Amy R Nelson, Axel Montagnej, et al. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease[J].Nat Rev Neurosci, 2017, 18(7): 419-434.
[22] 邓敏，章军建，沈军，等.丰富环境对慢性脑低灌注大鼠低氧诱导因子血管内皮生长因子的表达及其认知功能的影响[J].中华老年医学杂志,2016,35(1):79-84.
[23]Xing Meng-ya, Sun Qing-na, Wang Yi-yi, et al. Hydroxysafflor yellow A increase BDNF and NMDARs in the hippocampus in a vascular dementia rat model[J].Brain Res, 2016, 1642: 419-425.
[24] 张君，程笑，杨欢，等.山奈酚对慢性脑缺血大鼠学习记忆能力的影响及机制探讨[J].中国药理学通报,2017,33(1):39-44.
[25]Janine R Anastacio, Carlos Alexandre Netto, Cibele Canal Castro, et al. Resveratrol treatment has neuroprotective effects and prevents cognitive impairment after chronic cerebral hypoperfusion[J]. Neurol Res, 2014, 36(7): 627-633.
[26] 孟敏，李林. 双侧颈总动脉结扎致血管性痴呆大鼠模型研究进展[J].中国康复理论与实践, 2018, 24(3): 309-312.
[27] Masafumi Ihara, Hidekazu Tomimoto. Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes [J]. J Aging Res, 2011, 2011: 978761-978774.
[28]Keiko Nishio, Masafumi Ihara, Nobuyuki Yamasaki, et al. A mouse model characterizing features of vascular dementia with hippocampal atrophy[J].Stroke, 2010, 41(6): 1278-1284.
[29] 项颖，孙莉，邸琳，等.益气补肾活血胶囊对双侧颈总动脉狭窄所致大鼠轻度认知障碍的影响[J].中国医药指南,2015,13(29):41-43.
[30] 王蕊，杨秦飞，唐一鹏，等.大鼠拟“血管性痴呆”模型的改进[J].中国病理生理杂志，2000,16,(10):914-916.
[31] Eszter Farkas, Gergely Donka, Rob A I de Vos, et al. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain[J].Acta Neuropathol, 2004, 108(1): 57-64.

Exploration of Pathological Mechanism of Vascular Dementia Induced by Chronic Cerebral Hypoperfusion and Production of Several Common Animal Models

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

[1]	MA Jie-hua, WANG Mu-tong, GUO Fan, LIU Xu, WANG Yue-yao, ZHAO Yu, ZHANG Hui.Exploration of the Therapeutic Effect of Ultrasound Microbubble- Assisted Therapy on Cerebral Ischemia-Reperfusion Injury in Rats[J]. ACTA NEUROPHARMACOLOGICA, 2024, 14(4): 34-.
[2]	LI Shan-shan, BAI Mei-ling, ZHANG Lin-xi.Research Progress on the Mechanism of Nerve Cell Injury Under Oxygen Glucose Deprivation[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(1): 35-40.
[3]	LIU Zi - ming, GUO Bao, ZHANG Dan - shen, JING Yong - shuai.Role of Microglia in Different States on the Pathogenesis of Cerebral Ischemia[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(1): 57-64.
[4]	GENG Yu-han, ZHANG Dan-shen.Research Progress on the Protective Effect of Astrocytes in Cerebral Ischemia-Reperfusion Injury[J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(3): 20-24.
[5]	XIE Jia-jia, SUN Ting, ZHANG Dan-shen.Regulation of Mitochondrial Autophagy and Its Role in Cerebral Ischemia-Reperfusion Injury[J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(3): 43-49.
[6]	SUN Ting, XIE Jia-jia, ZHANG Dan-shen. Research Progress of Mitochondrial Permeability Transition Pore in Cerebral Ischemia-Reperfusion Injury[J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(2): 26-31.
[7]	LI Zhao-zhen, ZHANG Dan-shen.Research Progress on Related Mechanisms of Cerebral Ischemia-Reperfusion Injury[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(6): 60-63.
[8]	ZHANG Hao-nan, YANG Hui.Recent Advances in the Research of the Protective Effect of Natural Drugs on Cerebral Ischemia-Reperfusion Injury[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 14-20.
[9]	ZHENG Bei-bei, FENG Shuo, GUO Meng-yuan, FENG Pu, CEN Juan, ZHANG Feng.The Role of Reactive Oxygen Species in Promoting Angiogenesis and Its Important Role in Intracerebral Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 24-28.
[10]	ZHANG Dan-shen1，MA Jia-cheng2.Methods and Evaluation of Animal Models of Induced Pulmonary Fibrosis[J]. Acta Neuropharmacologica, 2019, 9(6): 15-20.
[11]	ZHANG Dan-shen，ZHANG Jian-mei.Methods and Evaluation of Animal Models of Induced Pneumonia[J]. Acta Neuropharmacologica, 2019, 9(5): 17-23.
[12]	ZHANG Dan-shen，LI Lan.Methods and Evaluation of Animal Models of Induced Emphysema[J]. Acta Neuropharmacologica, 2019, 9(5): 30-33.
[13]	ZHANG Dan-shen，WANG Fei-fan.Methods and Evaluation of Animal Models of Induced Pulmonary Edema[J]. Acta Neuropharmacologica, 2019, 9(5): 34-39.
[14]	ZHANG Dan-shen，ZHANG Nan.Methods and Evaluation of Animal Models of Induced Bronchial Asthma[J]. Acta Neuropharmacologica, 2019, 9(4): 1-8.
[15]	MIAO Ming-san，PENG Meng-fan，FANG Xiao-yan，JIA Jiao-jiao，BAI Ming.Effects of Sargentodoxacuneata Total Phenolic Acids on Oxidative Stress Level and Energy Metabolism of Brain Tissues in Rats with Cerebral Ischemia Reperfusion Injury[J]. Acta Neuropharmacologica, 2019, 9(1): 1-5.